PRESS RELEASE published on 04/01/2025 at 07:43, 1 year 5 months ago ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025 ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024, annonce l'obtention de l'autorisation de la FDA et des premières ventes commerciales du système ARC-EX ainsi que d'autres faits marquants Résultats Financiers Exercice 2024 ONWARD Medical Autorisation FDA ARC-EX
BRIEF published on 10/24/2024 at 07:41, 1 year 10 months ago ONWARD Medical lève 50 millions d'euros grâce à un investissement stratégique d'Ottobock Augmentation De Capital ONWARD Medical Investissement Ottobock Thérapie De La Moelle Épinière Système ARC-EX
BRIEF published on 10/24/2024 at 07:41, 1 year 10 months ago ONWARD Medical Raises EUR 50 Million with Strategic Investment from Ottobock Capital Increase ONWARD Medical Ottobock Investment Spinal Cord Therapy ARC-EX System
PRESS RELEASE published on 10/24/2024 at 07:36, 1 year 10 months ago ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA ONWARD® Medical raises EUR 50 million with strategic investment from Ottobock SE & Co. KGaA, extending cash runway. Ottobock acquires c.10% share capital, initiating collaboration for spinal cord injury therapies Investment EUR 50 Million ONWARD Medical Ottobock SE & Co. KGaA Spinal Cord Injury Therapies
BRIEF published on 10/22/2024 at 17:57, 1 year 10 months ago ONWARD Medical lance une augmentation de capital de 40 millions d'euros avec la participation d'Ottobock Placement Privé Augmentation De Capital ONWARD Medical Investissement Ottobock Thérapie De La Colonne Vertébrale
BRIEF published on 10/22/2024 at 17:57, 1 year 10 months ago ONWARD Medical Initiates €40 Million Capital Increase with Ottobock's Involvement Private Placement Capital Increase ONWARD Medical Ottobock Investment Spinal Therapy
PRESS RELEASE published on 10/22/2024 at 17:52, 1 year 10 months ago ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA ONWARD Medical launches capital increase of c. EUR 40 million with EUR 22.5 million cornerstone investment from Ottobock SE & Co. KGaA, aiming to develop spinal cord stimulation therapies for spinal cord injury patients Capital Increase Ottobock ONWARD Medical EUR 40 Million Spinal Cord Stimulation
BRIEF published on 10/15/2024 at 07:38, 1 year 10 months ago ONWARD Medical obtains exclusive rights to WIMAGINE BCI technology ONWARD Medical BCI WIMAGINE ARC-BCI System Paralysis Brain-machine Interface
BRIEF published on 10/15/2024 at 07:38, 1 year 10 months ago ONWARD Medical obtient les droits exclusifs de la technologie BCI WIMAGINE ONWARD Medical BCI WIMAGINE Système ARC-BCI Paralysie Interface Cerveau-machine
PRESS RELEASE published on 10/15/2024 at 07:33, 1 year 10 months ago ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec ONWARD Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d'interface cerveau machine WIMAGINE de Clinatec, visant à restaurer les mouvements guidés par la pensée après une paralysie Technologie CEA ONWARD Medical Interface Cerveau Machine WIMAGINE
Published on 09/12/2026 at 02:35, 1 day 2 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 6 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 7 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 12 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 11 hours 31 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 21 hours 51 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 7 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 7 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 9 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 22 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 22 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 9 hours ago Availability of the 2026 Interim Financial Report